{"entity":"novartis","id":"ent_novartis","name":"Novartis","from":"2025-11-08","to":"2026-11-08","page":"https://asof.is/record/novartis/diff?from=2025-11-08&to=2026-11-08","summary":"Between 2025-11-08 and 2026-11-08, Novartis's record changed in 5 facts: 5 replaced (net income $11.94 billion → $13.97 billion; operating income $14.54 billion → $17.64 billion; shares outstanding 1.98 billion shares → 1.91 billion shares and 2 more); 13 unchanged.","counts":{"changed":5,"added":0,"ended":0,"replaced":5,"unchanged":13,"skipped_posts":{"from":0,"to":0}},"by_predicate":[{"predicate":"net_income","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"operating_income","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"shares_outstanding","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"total_assets","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"total_equity","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"ceo","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"cik","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"fiscal_year_end","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"headquarters","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"listed_on","added":0,"ended":0,"replaced":0,"unchanged":2},{"predicate":"registrant_name","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"sic_industry","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"state_of_incorporation","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"ticker","added":0,"ended":0,"replaced":0,"unchanged":2},{"predicate":"website","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"x_username","added":0,"ended":0,"replaced":0,"unchanged":1}],"added":[],"ended":[],"replaced":[{"predicate":"net_income","from":{"id":"clm_5BF3DA7B810B","predicate":"net_income","value":"11,939,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 11,939,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_5BF3DA7B810B, https://asof.is/claim/clm_5BF3DA7B810B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_5BF3DA7B810B","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8E9D1CC51F75","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2024, filed 2025-01-31"}},"to":{"id":"clm_8E9D1CC51F75","predicate":"net_income","value":"13,967,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 13,967,000,000 United States dollar\", as of 2025-12-31. Claim clm_8E9D1CC51F75, https://asof.is/claim/clm_8E9D1CC51F75, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_8E9D1CC51F75","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2025, filed 2026-02-04"}}},{"predicate":"operating_income","from":{"id":"clm_2DD252AFDAA3","predicate":"operating_income","value":"14,544,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 14,544,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_2DD252AFDAA3, https://asof.is/claim/clm_2DD252AFDAA3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_2DD252AFDAA3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_13AEEBEB19A6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2024, filed 2025-01-31"}},"to":{"id":"clm_13AEEBEB19A6","predicate":"operating_income","value":"17,644,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 17,644,000,000 United States dollar\", as of 2025-12-31. Claim clm_13AEEBEB19A6, https://asof.is/claim/clm_13AEEBEB19A6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_13AEEBEB19A6","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2025, filed 2026-02-04"}}},{"predicate":"shares_outstanding","from":{"id":"clm_5B7C7456996A","predicate":"shares_outstanding","value":"1,975,089,248 shares","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 1,975,089,248 shares\", as of 2024-12-31 (until 2025-12-31). Claim clm_5B7C7456996A, https://asof.is/claim/clm_5B7C7456996A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_5B7C7456996A","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_29E1C56666EB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2024, filed 2025-01-31"}},"to":{"id":"clm_29E1C56666EB","predicate":"shares_outstanding","value":"1,908,151,679 shares","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 1,908,151,679 shares\", as of 2025-12-31. Claim clm_29E1C56666EB, https://asof.is/claim/clm_29E1C56666EB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_29E1C56666EB","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2025, filed 2026-02-04"}}},{"predicate":"total_assets","from":{"id":"clm_BCE8770D5AC4","predicate":"total_assets","value":"102,246,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 102,246,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_BCE8770D5AC4, https://asof.is/claim/clm_BCE8770D5AC4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_BCE8770D5AC4","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0705199BCCFC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2024, filed 2025-01-31"}},"to":{"id":"clm_0705199BCCFC","predicate":"total_assets","value":"110,949,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 110,949,000,000 United States dollar\", as of 2025-12-31. Claim clm_0705199BCCFC, https://asof.is/claim/clm_0705199BCCFC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_0705199BCCFC","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2025, filed 2026-02-04"}}},{"predicate":"total_equity","from":{"id":"clm_DD45194F44A3","predicate":"total_equity","value":"44,126,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-01-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 44,126,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_DD45194F44A3, https://asof.is/claim/clm_DD45194F44A3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.","url":"https://asof.is/claim/clm_DD45194F44A3","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6DC4BBC10979","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-01-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2024, filed 2025-01-31"}},"to":{"id":"clm_6DC4BBC10979","predicate":"total_equity","value":"46,549,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 46,549,000,000 United States dollar\", as of 2025-12-31. Claim clm_6DC4BBC10979, https://asof.is/claim/clm_6DC4BBC10979, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_6DC4BBC10979","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2025, filed 2026-02-04"}}}],"rule":"Two states compared by claim id: in both, unchanged; only on to, added; only on from, ended. An ended and an added claim on one predicate are a replacement when the ended one points to the added (superseded_by), or the predicate has exactly one of each and the added begins the day the ended ends. Added rows are labelled for to, ended rows for from. Posts and Hugging Face repos are counted in skipped_posts, not listed.","legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}